Bharat Parenterals Limited (BOM:541096)

Bharat Parenterals Balance Sheet

Financials in millions INR. Fiscal year is April - March.

Assets

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Cash & Equivalents	119.31	442.9	492.25	78.52	33.99
Short-Term Investments	50	-	-	10.76	200.21
Trading Asset Securities	-	-	-	-	114.82
Cash & Short-Term Investments	169.31	442.9	492.25	89.28	349.02
Cash Growth	-61.77%	-10.03%	451.33%	-74.42%	-21.54%
Accounts Receivable	1,507	1,717	1,414	1,124	734.03
Other Receivables	-	27.46	10.89	7.4	16.99
Receivables	1,508	1,746	1,426	1,132	752.33
Inventory	847.15	719.52	614.68	378.42	207.6
Other Current Assets	576.2	646.83	86.93	243	128.41
Total Current Assets	3,101	3,555	2,620	1,843	1,437
Property, Plant & Equipment	2,355	2,291	2,336	1,402	654.09
Long-Term Investments	10.96	-	-	25.44	23.37
Goodwill	521	521	-	-	-
Other Intangible Assets	15.1	11.74	10.45	-	-
Long-Term Deferred Tax Assets	21.07	8.34	1.17	-	-
Other Long-Term Assets	108.56	98.05	72.87	233.11	145.75
Total Assets	6,133	6,485	5,040	3,503	2,261

Liabilities

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Accounts Payable	639.47	741.62	594.76	513.43	237.64
Accrued Expenses	7.28	75.72	61.44	35.26	22.88
Short-Term Debt	-	998.91	808.49	360.22	27.79
Current Portion of Long-Term Debt	243.19	44.41	35.69	28.03	24.77
Current Income Taxes Payable	-	2.46	-	5.32	9.2
Other Current Liabilities	683.99	329.92	397.89	255.73	93.03
Total Current Liabilities	1,574	2,193	1,898	1,198	415.31
Long-Term Debt	1,218	758.67	731.62	109.2	124.9
Pension & Post-Retirement Benefits	-	23.11	11.86	6.21	2.57
Long-Term Deferred Tax Liabilities	-	-	-	3.99	9.55
Other Long-Term Liabilities	225.31	120.52	16.95	7.05	6.81
Total Liabilities	3,017	3,095	2,659	1,324	559.15

Shareholders' Equity

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Common Stock	68.92	68.92	58.2	57.75	57.75
Additional Paid-In Capital	-	1,488	25.95	15.24	15.24
Retained Earnings	-	1,750	1,889	1,750	1,585
Comprehensive Income & Other	3,153	-	-	5.31	-
Total Common Equity	3,222	3,307	1,973	1,828	1,658
Minority Interest	-106.53	83.25	409.07	351.03	43.17
Shareholders' Equity	3,116	3,390	2,382	2,179	1,701
Total Liabilities & Equity	6,133	6,485	5,040	3,503	2,261

Additional Metrics

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Total Debt	1,461	1,802	1,576	497.45	177.46
Net Cash (Debt)	-1,292	-1,359	-1,084	-408.16	171.56
Net Cash Growth	-	-	-	-	-46.79%
Net Cash Per Share	-318.95	-207.37	-186.12	-70.68	29.89
Filing Date Shares Outstanding	4.05	6.89	5.82	5.77	5.77
Total Common Shares Outstanding	4.05	6.89	5.82	5.77	5.77
Working Capital	1,527	1,362	721.76	644.85	1,022
Book Value Per Share	795.60	479.79	338.97	316.55	287.16
Tangible Book Value	2,686	2,774	1,962	1,828	1,658
Tangible Book Value Per Share	663.24	402.49	337.17	316.55	287.16
Land	-	48.18	48.18	51.84	41.53
Buildings	-	759.19	746.01	161.65	146.73
Machinery	-	1,891	1,764	587.17	541.5
Construction In Progress	-	302.19	238.92	990.14	256.54

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jul 25, 2026

Data Sources Report a data error